𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Concentrations of β-Phenylethylamine in Plasma and Plateletes of Schizophrenics

✍ Scribed by Tetsuro Myojin; Chiaki Taga; Motohiro Tsuji

Book ID
118708340
Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
341 KB
Volume
43
Category
Article
ISSN
1323-1316

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Determination of β-phenylethylamine conc
Determination of β-phenylethylamine concentrations in human plasma, platelets, and urine and in animal tissues by high-performance liquid chromatography with fluorometric detection
✍ Motohiro Tsuji; Ken Ohi; Chiaki Taga; Tetsuro Myojin; Saburo Takahashi 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 449 KB

A highly sensitive method for the determination of &phenylethylamine in human plasma, platelets, and urine and in mouse tissue is described. The method is based on a two-step isolation using cation-exchange columns followed by reversephase high-performance liquid chromatography with fluorometric det

The Measurement of β-Phenylethylamine in
The Measurement of β-Phenylethylamine in Human Plasma and Rat Brain
✍ N.D. Huebert; V. Schwach; G. Richter; M. Zreika; C. Hinze; K.D. Haegele 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 463 KB

A sensitive and specific analytical method has been developed for the measurement of beta-phenylethylamine (PEA) in human plasma and rat brain extracts. The method involves solvent extraction of PEA with cyclohexane in the presence of amphetamine or phenylpropylamine (PPA) as internal standards. Aut

Phenylethylamine and phenylacetic acid i
Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls
✍ Helmut Beckmann; Gavin P. Reynolds; Merton Sandler; Peter Waldmeier; Joachim Lau 📂 Article 📅 1982 🏛 Springer-Verlag 🌐 English ⚖ 509 KB

Phenylethylamine (PEA) is an endogenous substance with amphetamine-like stimulant properties. On the basis of this ability an abnormal brain PEA metabolism has been proposed as an etiological factor in some forms of schizophrenia. In the present study 28 schizophrenic patients and 15 healthy control